One of them, called APOE4, has been linked to a much higher risk of developing Alzheimer's disease, and carriers often have ...

That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...

The effects of a treatment with AEF0217 were also studied as a function of the APOE4 genotype (APOE4-positive versus APOE4 ..

For example, someone with the APOE4 variant is more likely to develop Alzheimer’s disease, the most common form of dementia.

Memory naturally declines with age, affecting life quality and work productivity. However, not all memory loss signals ...